Overview
Oxford Nanopore are sponsoring, exhibiting and presenting at Association of Public Health Laboratories (APHL) 2025. The conference is an in-person only event for the public health laboratory community, bringing together leaders, scientists, influencers and partners to share issues, trends and best practices driving laboratory science and public health today.
Details for the Oxford Nanopore Innovate Session below.
Please also visit us at booth# 115 if you are able to attend the conference.
Innovate! session registration
Date: Monday, May 5, 2025
Time: 12:00 pm–12:30 pm PST
Location: B113-114
Improving Public Health Testing with Nanopore Sequencing
In this talk we will describe work to develop and validate nanopore sequencing tests for samples and isolates, including Mycobacterium tuberculosis (MTB) and other bacterial pathogens. We will discuss established protocols that cover extraction methods, flow cells, PCR primers, sequencing, and bioinformatics analysis. In addition we will describe the validation testing for sensitivity, specificity, and accuracy, comparing results to gold standard methods. Nanopore sequencing was found to replace older techniques such as Sanger sequencing and PFGE. These methods were used for predicting MTB antimicrobial resistance, identifying unknown bacteria, and conducting SNP analysis, offering accurate, efficient, and cost-effective solutions for public health testing.
Space is limited so be sure to register in advance.
Please contact events@nanoporetech.com with any questions.
Innovate! session speaker
)
Kimberlee A. Musser, Ph.D., Clinical Director, Wadsworth Center, David Axelrod Institute
Kimberlee Musser, Ph.D. is the Clinical Director and the Chief of Bacterial Disease for the Wadswort...